An Ounce of Prevention, a Pound of Cure: Social Media Risks and Benefits for the Pharmaceutical Industry - White Paper

Drug makers are just beginning to realize how social networks can improve business results. But what seems like a spoon full of sugar is often a tough pill to swallow when you consider regulatory requirements from agencies like the FDA for use of these networks. Read this paper to gain an understanding of what the regulatory landscape of the pharmaceuticals industry looks like, and what concerns you should be aware of from a legal perspective.

Download this free white paper now - Click Here

Provided by: Actiance